Share Email Print

Proceedings Paper

Photobiomodulation reduces photoreceptor death and regulates cytoprotection in early states of P23H retinal dystrophy
Author(s): Diana K. Kirk; Sandeep Gopalakrishnan; Heather Schmitt; Betsy Abroe; Michele Stoehr; Adam Dubis; Joseph Carroll; Jonathan Stone; Krisztina Valter; Janis Eells
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Irradiation by light in the far-red to near-infrared (NIR) region of the spectrum (photobiomodulation, PBM) has been demonstrated to attenuate the severity of neurodegenerative disease in experimental and clinical studies. The purpose of this study was to test the hypothesis that 670 nm PBM would protect against the loss of retinal function and improve photoreceptor survival in a rodent model of retinitis pigmentosa, the P23H transgenic rat. P23H rat pups were treated once per day with a 670 nm LED array (180 sec treatments at 50 mW/cm2; fluence 9 joules/cm2) (Quantum Devices Inc., Barneveld WI) from postnatal day (p) 16-20 or from p10-20. Sham-treated rats were restrained, but not exposed to NIR light. The status of the retina was determined at p22 by assessment of mitochondrial function, oxidative stress and cell death. In a second series of studies, retinal status was assessed at p30 by measuring photoreceptor function by ERG and retinal morphology by Spectral Domain Optical Coherence Tomography (SD-OCT). 670 nm PBM increased retinal mitochondrial cytochrome oxidase activity and upregulated the retina’s production of the key mitochondrial antioxidant enzyme, MnSOD. PBM also attenuated photoreceptor cell loss and improved photoreceptor function. PBM protects photoreceptors in the developing P23H retina, by augmenting mitochondrial function and stimulating antioxidant protective pathways. Photobiomodulation may have therapeutic potential, where mitochondrial damage is a step in the death of photoreceptors.

Paper Details

Date Published: 5 March 2013
PDF: 10 pages
Proc. SPIE 8569, Mechanisms for Low-Light Therapy VIII, 85690F (5 March 2013); doi: 10.1117/12.981791
Show Author Affiliations
Diana K. Kirk, Australian National Univ. (Australia)
Sandeep Gopalakrishnan, The Univ. of Wisconsin-Milwaukee (United States)
Heather Schmitt, The Univ. of Wisconsin-Milwaukee (United States)
Betsy Abroe, The Univ. of Wisconsin-Milwaukee (United States)
Michele Stoehr, Medical College of Wisconsin (United States)
Adam Dubis, Medical College of Wisconsin (United States)
Joseph Carroll, Medical College of Wisconsin (United States)
Jonathan Stone, The Univ. of Sydney (Australia)
Krisztina Valter, Australian National Univ. (Australia)
Janis Eells, The Univ. of Wisconsin-Milwaukee (United States)

Published in SPIE Proceedings Vol. 8569:
Mechanisms for Low-Light Therapy VIII
Michael R. Hamblin; Juanita Anders; James D. Carroll; Praveen R. Arany, Editor(s)

© SPIE. Terms of Use
Back to Top